A settlement has been reached to resolve False Claims Act allegations against Spectranetics Corporation who is accused of causing false claims to be submitted to the Medicare Program.
The United States allegations were that the company illegally imported unapproved medical devices and provided them to physicians for use in patients, conducted a clinical study in a manner that failed to comply with federal regulations and promoted certain products for procedures for which the company had not received Food and Drug Administration approval or clearance.